Target intelligence / Profile preview

Microbial DNA replication enzyme

Molecular classification
Enzyme, DNA polymerase family, Topoisomerase family, Helicase family, Ligase family
01

Overview

Microbial DNA replication enzymes refer collectively to the proteins that orchestrate the copying of microbial (usually prokaryotic) DNA prior to cell division. This includes DNA polymerases that synthesize the new DNA strand, helicases that unwind the double helix, topoisomerases (including DNA gyrase and topoisomerase IV) that manage DNA supercoiling and unlink daughter chromosomes, DNA ligases that seal nicks in the DNA backbone, primases that synthesize RNA primers for DNA synthesis, and accessory proteins (e.g., single-stranded binding proteins, clamps, clamp loaders). These enzymes are essential for microbial survival, highly conserved across species, and are validated targets for antimicrobial drug discovery, with several classes of antibiotics (notably fluoroquinolones and aminocoumarins) exerting effects by inhibiting topoisomerases. Many replication enzymes remain underexploited as antibiotic targets, and emerging resistance has made these targets increasingly critical in the search for new treatments.

Other names
DNA replication enzyme (microbial)bacterial DNA replication machinerymicrobial replisome component
02

Mechanism of action

Inhibition of DNA gyrase: interferes with supercoiling and decatenation of DNA Poisoning of topoisomerase IV: blocks chromosome segregation β-clamp inhibition: disrupts processivity of DNA polymerase DNA ligase inhibition: blocks sealing of DNA nicks, preventing chromosome integrity Helicase/primase inhibition: disrupts strand separation or primer synthesis (less developed clinically)

03

Biological functions

DNA replicationCell divisionGenetic information transmissionDNA repair (for some enzymes)Genome stability
04

Disease associations

Infection (essential for microbial survival and proliferation; thus, key in infectious disease)Resistance development (mutations can result in antibiotic resistance)
05

Safety considerations

Off-target inhibition of eukaryotic homologs in host (e.g., mitochondrial topoisomerases, polymerases)Development of antibiotic resistance by target mutationComplex multi-protein interactions may hinder specific targetingDrug specificity for bacterial versus host enzymes (mitigated for NAD+-dependent DNA ligase, which is not used by eukaryotes)
06

Interacting drugs

Fluoroquinolones (e.g., ciprofloxacin, moxifloxacin; target DNA gyrase/topoisomerase II)

5 more in the full profile.

07

Biomarkers

gyrA/parC mutations (predict fluoroquinolone resistance)Target gene mutations (e.g., in ligA, dnaN, etc., for development of resistance)

Beyond the preview

Go deeper on Microbial DNA replication enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial DNA replication enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call